Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

INIS

• risks 100%
• cholesterol 100%
• density 64%
• lipoproteins 64%
• therapy 41%
• clinical trials 29%
• patients 29%
• adults 29%
• panels 29%
• management 17%
• levels 11%
• drugs 11%
• education 11%
• guidelines 11%
• triglycerides 11%
• obesity 5%
• modifications 5%
• reviews 5%
• people 5%
• reduction 5%
• algorithms 5%
• recommendations 5%
• inclusions 5%
• nicotinic acid 5%

Medicine and Dentistry

• Combination Therapy 70%
• Low Density Lipoprotein Cholesterol 52%
• Therapeutic Procedure 41%
• Cholesterol 35%
• Person 35%
• Motivation 35%
• Adult 29%
• Patient 23%
• High Density Lipoprotein Cholesterol 11%
• Triacylglycerol 11%
• Lifestyle Modification 11%
• Obesity 5%
• Metabolic Syndrome 5%
• Drug Therapy 5%
• Clinical Management 5%
• Patient with Diabetes 5%
• Lifestyle 5%
• Chemotherapeutic Agent 5%
• Drug 5%
• Physical Inactivity 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 58%
• Low Density Lipoprotein Cholesterol 52%
• Cholesterol 35%
• High Density Lipoprotein Cholesterol 11%
• Triacylglycerol 11%
• Statin (Protein) 5%
• Obesity 5%
• Metabolic Syndrome X 5%
• Nicotinic Acid 5%
• Drug 5%
• Fibric Acid Derivative 5%